Showing results (181-190 of 369) with videos related to
Sort By:
Pageof 37
Investigational New Drugs|November 1, 2013
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of TumorsRobin L Jones, Stefano Ferrari, Jean Yves Blay, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 12, 2017
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma PatientSeth M Pollack, Hailing Lu, Sacha Gnjatic, et al.Sarcoma|July 13, 2016
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue SarcomasJoanna Vitfell-Rasmussen, Ian Judson, Akmal Safwat, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 19, 2020
Primary iliocaval leiomyosarcomas: The path beyond surgeryChin-Ann J Ong, Myles J Smith, Hayden A Snow, et al.Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.Anticancer Research|December 8, 2020
Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft TissueElena Cojocaru, Khin Thway, Cyril Fisher, et al.Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho, Dawn Steele, Silvana Di Palma, et al.ESMO Open|July 19, 2018
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcomaAnna Maria Frezza, Alex T J Lee, Eran Nizri, et al.Pageof 37